MedTrace Logo

The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes

NCT01855386 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2018-11-08

No results posted yet for this study

Summary

The thought is that Non-Alcoholic Fatty Liver Disease (NAFLD) plays a key role in the progression to prediabetes/T2DM in those with a history of Gestational Diabetes (GDM). The investigators want to know if having a fatty liver will be connected with more glucose abnormalities (higher fasting/oral glucose tolerance test glucose, more insulin resistance) and that a history of GDM will be common in those with NAFLD.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy

Interventions

OTHER

Subjects with Gestational Diabetes

Subjects with a history of Gestational Diabetes will provide blood samples, blood pressure measured with a blood pressure cuff, pulse, height, weight, and ultrasound of the liver at the 6 week postpartum and 6 month postpartum visits.

OTHER

Controls without Gestational Diabetes

Matched control subjects without gestational diabetes will provide blood samples, blood pressure measured with a blood pressure cuff, pulse, height, weight, and ultrasound of the liver at the 6 week postpartum and 6 month postpartum visits.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Maryam Sattari, MD · University of Florida

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2017-05-31
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01855386 on ClinicalTrials.gov